Mechanism
Dopaminergic neural precursor cells
Assets acting on this target.
- Class
- Allogeneic iPSC-derived cell therapy
- Notes
- audit finding #1155 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT06978920
Mechanism
Assets acting on this target.
1 of 1 assets